Paclitaxel: What has been done and the challenges remain ahead

International Journal of Pharmaceutics
Ezequiel BernabeuDiego A Chiappetta

Abstract

In recent years, the nanotechnology has offered researchers the opportunity to solve the problems caused by the vehicle of the standard and first formulation of paclitaxel (Taxol®), while maximizing the proven antineoplastic activity of the drug against many solid tumors. Hence, different types of nanocarriers have been employed to improve the efficacy, safety, physicochemical properties and pharmacokinetic/pharmacodynamic profile of this drug. To date, paclitaxel is the unique drug that is marketed in three different nanoplatforms for its parenteral delivery: polymeric nanoparticles (Abraxane®), liposomes (Lipusu®), and polymeric micelles (Genexol®, Nanoxel® and Paclical®). Indeed, a fourth nanocarrier might be available soon, because phase III studies of Opaxio™, a polymeric-conjugated, are near completion. Furthermore, other several nanoformulations are currently in various stages of clinical trials. Therefore, it is only through the critical analysis of clinical evidence from these studies that we can get a more concrete idea of what has been achieved with pharmaceutical nanotechnology so far. This review attempts to summarize current information available regarding the clinical status and the physicochemical characteristic...Continue Reading

References

Feb 22, 1979·Nature·P B SchiffS B Horwitz
Oct 1, 1994·Clinical Pharmacokinetics·D S Sonnichsen, M V Relling
Jan 1, 1994·Pharmacotherapy·D R Kohler, B R Goldspiel
Apr 10, 1999·Molecular Biology of the Cell·A M YvonM A Jordan
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·J P SnyderE Nogales
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S C KimM H Seo
Mar 7, 2002·International Journal of Pharmaceutics·Anil K SinglaDeepika Aggarwal
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maurie MarkmanMark Baker
Feb 27, 2003·The Journal of Investigative Dermatology·Rainer KunstfeldPeter Petzelbauer
Jul 8, 2003·Clinical Pharmacokinetics·Albert J ten TijeAlex Sparreboom
Mar 11, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O SoepenbergJ Verweij
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Sebastian StriethMarc Dellian
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric P WinerLarry Norton
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tae-You KimYung-Jue Bang
Jul 22, 2004·Expert Opinion on Pharmacotherapy·Sakkaraiappan Ramalingam, Chandra P Belani
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul SabbatiniDavid Spriggs
Nov 30, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J Allen ZhangImran Ahmad
Feb 16, 2005·Cancer Chemotherapy and Pharmacology·Maria Luisa VeronesePeter J O'Dwyer
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alphonse G TaghianSimon N Powell
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex SparreboomNeil Desai
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesP M Ravdin
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W NymanDaniel D Von Hoff
Nov 22, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jack W Singer
Nov 24, 2005·International Journal of Pharmaceutics·Donald E Owens, Nicholas A Peppas
Aug 23, 2006·Cancer Chemotherapy and Pharmacology·Scott A ShafferJack W Singer
Aug 29, 2006·Drug Discovery Today·Arun K IyerHiroshi Maeda
Mar 29, 2007·International Journal of Cancer. Journal International Du Cancer·Yiyao LiuMichihiro Nakamura
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 20, 2007·Expert Opinion on Drug Safety·Neena I MarupudiHenry Brem
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naiyer A RizviMark G Kris
Jun 17, 2008·The Oncologist·Richard Pazdur
Jul 3, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Mary E R O'BrienJack W Singer
Jul 11, 2008·Current Neuropharmacology·Charity D ScriptureAlex Sparreboom
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sebastian StriethMarc Dellian

❮ Previous
Next ❯

Citations

Jan 18, 2018·International Journal of Molecular Sciences·Ana M L Seca, Diana C G A Pinto
Dec 14, 2018·The Journal of Cell Biology·Julia Tischer, Fanni Gergely
Aug 15, 2019·Drug Development Research·Hang HuDefeng Xu
Jan 25, 2020·Nanomaterials·Jorge F Pontes, Ana Grenha
Feb 1, 2020·Recent Patents on Anti-cancer Drug Discovery·Hongyu TaoXiukun Lin
Sep 19, 2019·Expert Opinion on Drug Delivery·Ludger M Ickenstein, Patrick Garidel
Dec 20, 2019·Dose-response : a Publication of International Hormesis Society·Xiao HuangZhijun Yang
Jul 24, 2020·Dose-response : a Publication of International Hormesis Society·Lina YanSaijun Lu
Aug 22, 2020·International Journal of Nanomedicine·Kyungeun Kim, Dongwoo Khang
Sep 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hui Shan LiewMay Lee Low
Sep 19, 2020·Nanomedicine·Alexsandra Conceição ApolinárioLuciana Biagini Lopes
Jul 3, 2019·Nanomaterials·Celia NietoEva M Martín Del Valle
Jul 10, 2019·Anti-cancer Agents in Medicinal Chemistry·Manjula Vinayak, Akhilendra K Maurya
Aug 2, 2019·Cancer Chemotherapy and Pharmacology·A I Fraguas-SánchezA I Torres-Suárez
Dec 11, 2020·Acta Biomaterialia·Mohammad Norouzi, Pierre Hardy
Jan 12, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Luciana MoscaGianni Colotti
Aug 11, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhaohua Richard HuangDaryl C Drummond
Aug 30, 2019·Journal of Photochemistry and Photobiology. B, Biology·Elisa GaioElena Reddi
Jan 28, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Can LeiTao Zou
Oct 7, 2019·Drug Discovery Today·Mohammad NorouziFatemeh Atyabi
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Filip BorysHanna Krawczyk
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Julia Jiménez-LópezJosé Prados
Nov 19, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wamidh H TalibAsma Ismail Mahmod
Dec 29, 2020·Frontiers in Pharmacology·Jinfeng ShiChaomei Fu
Dec 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Julia Gallego-JaraTeresa de Diego Puente

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Nanomedicine
Satomi OnoueHak-Kim Chan
International Journal of Nanomedicine
Rama Mallipeddi, Lisa Cencia Rohan
© 2022 Meta ULC. All rights reserved